Sanchez Ramiro 4
4 · Cerevel Therapeutics Holdings, Inc. · Filed Dec 11, 2023
Insider Transaction Report
Form 4
Sanchez Ramiro
Chief Medical Officer
Transactions
- Sale
Common Stock
2023-12-07$41.37/sh−10,000$413,700→ 0 total - Exercise/Conversion
Common Stock
2023-12-07$3.50/sh+10,000$35,000→ 10,000 total - Exercise/Conversion
Stock Option (Right to Buy)
2023-12-07−10,000→ 548,435 totalExercise: $3.50Exp: 2029-02-27→ Common Stock (10,000 underlying)
Footnotes (2)
- [F1]These transactions were effected pursuant to a Rule 10b5-1 trading plan dated August 4, 2023 adopted by the Reporting Person.
- [F2]25% of the shares subject to this option vested and became exercisable on January 14, 2020, with the remainder vesting in thirty-six (36) equal monthly installments thereafter.